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Abstract
Background: Advances in intensive care support such as therapeutic hypothermia or new liver assist devices have
been the mainstay of treatment attempting to bridge the gap from acute liver failure to liver transplantation, but
the efficacy of the available devices in reducing mortality has been questioned. To address this issue, the present
animal study was aimed to analyze the pure clinical effects of a simple extracorporeal dummy device in an
anhepatic porcine model of acute liver failure.
Methods: Total hepatectomy was performed in ten female pigs followed by standardized intensive care support
until death. Five animals (dummy group, n = 5) underwent additional cyclic connection to an extracorporeal
dummy device which consisted of a plasma separation unit. The separated undetoxified plasma was completely
returned to the pigs circulation without any plasma substitution or exchange in contrast to animals receiving
intensive care support alone (control group, n = 5). All physiological parameters such as vital and ventilation
parameters were monitored electronically; laboratory values and endotoxin levels were measured every 8 hours.
Results: Survival of the dummy device group was 74 ± 6 hours in contrast to 53 ± 5 hours of the control group
which was statistically significant (p < 0.05). Body temperature 24 hours after hepatectomy was significantly lower
(36.5 ± 0.5°C vs. 38.2 ± 0.7°C) in the dummy device group. Significant lower values were measured for blood
lactate (1.9 ± 0.2 vs. 2.5 ± 0.5 mM/L) from 16 hours, creatinine (1.5 ± 0.2 vs. 2.0 ± 0.3 mg/dL) from 40 hours and
ammonia (273 ± 122 vs. 1345 ± 700 μg/dL) from 48 hours after hepatectomy until death. A significant rise of
endotoxin levels indicated the onset of sepsis at time of death in 60% (3/5) of the dummy device group animals
surviving beyond 60 hours from hepatectomy.
Conclusions: Episodes of slight hypothermia induced by cyclic connection to the extracorporeal dummy device
produced a significant survival benefit of more than 20 hours through organ protection and hemodynamic
stabilisation. Animal studies which focus on a survival benefit generated by liver assist devices should especially
address the aspect of slight transient hypothermia by extracorporeal cooling.
Background
Acute liver failure (ALF) is defined as rapid and progres-
sive development of severe acute liver injury with
impaired liver synthetic function without a previous
history of liver disease. Worsening encephalopathy and
cerebral edema escalating in brain stem herniation [1]
as well as infection and inflammation with development
of systemic inflammatory response syndrome (SIRS) fre-
quently contributing to multiple-organ failure in this
setting [2] are the main courses of death. The complex-
ity of metabolic abnormalities resulting from ALF is still
incompletely understood hence morbidity and mortality
among patients with ALF without liver transplantation
remains as high as 85% [3].
Animal models of ALF remain the mainstay of
research in development of more efficient artificial [4,5]
* Correspondence: Christian.Thiel@med.uni-tuebingen.de
1Department of General, Visceral and Transplant Surgery, Tuebingen
University Hospital, Hoppe-Seyler-Strasse 3, Tuebingen 72076, Germany
Full list of author information is available at the end of the article
Thiel et al. BMC Gastroenterology 2011, 11:79
http://www.biomedcentral.com/1471-230X/11/79
© 2011 Thiel et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.or bioartificial [6,7] liver assist devices as well as precli-
nical trials in newly developed therapeutic approaches.
Animal models of ALF are mainly based on surgical
techniques such as devascularisation [8], ischemia [9],
extensive/total liver resection [10,11] or medical inter-
ventions such as hepatic intoxication with acetamino-
phen [12], amanitin [13] or galactosamine [14].
Unfortunately all aforementioned models involve various
limitations, thus affecting morbidity in the assessment of
a given intervention. Although anhepatic models have
been criticized for their irreversibility and lack of circu-
lating products of cell necrosis or inflammatory media-
tors through the native liver, it is commonly considered
to serve as a suitable in vivo model for testing the effec-
tiveness of liver assist devices due to high reproducibility
and the total absence of remaining functional liver par-
enchyma [15-17]. But surprisingly the hereby demon-
strated survival benefit of the already established devices
could not be reproduced in clinical practise. Considering
this fact we decided to revaluate a simple dummy device
to verify if experimentally demonstrated survival benefits
are properly controlled for side-effects.
Preliminary pigs studies have been carried out to
establish a highly reproducible model of total hepatect-
omy [11] delivering long-term survival under standar-
dized intensive care conditions [18]. It has been
demonstrated experimentally and clinically that moder-
ate hypothermia is organ protective in specific life threa-
tening conditions such as cardiac arrest [19], traumatic
brain injury [20] or ALF [21]. It is also well known that
the use of extracorporeal circuits like hemofiltration,
plasmapheresis or liver assist devices result in moderate
peripheral cooling of the connected person. Although
recent ALF animal models have certainly been con-
trolled for hypothermia [22], various animal studies eval-
uating liver assist devices or other therapeutical
interventions did not report the exact courses of body
temperature while connection to the devices [15,23] or
did not even test their extracorporeal devices against a
dummy device group [23,24]. Assuming that these stu-
dies might not be properly controlled for extracorporeal
device associated transient hypothermia, we performed
t h ep r e s e n ts t u d yt oa n a l y z ead u m m yd e v i c ee f f e c t so n
hemodynamics, body temperature and survival.
Methods
Animal model of ALF
After approval by the institutional review board for ani-
mal experiments, ten female German Landrace pigs
weighing 36 ± 4 kg underwent total hepatectomy follow-
ing frontoparietal trepanation for intracranial pressure
(ICP) monitoring. All experiments were performed
according to the international principles governing
research on animals and under the supervision of a
veterinarian, who set the guidelines for minimizing pigs
suffering.
Anesthesia
Intramuscular premedication was administered using
atropine 0.1% (0.05 mg/kg), ketamine (7 mg/kg), azaper-
one (10 mg/kg) and diazepam (1 mg/kg). A core body
temperature of 38 ± 0.5°C measured by a rectal probe
was aimed by using warming blankets throughout the
experiment. A stomach tube (Argyle™,T y c oH e a l t h -
care, Tullamore, Ireland) was placed for intestinal drai-
nage. After oral intubation with a cuffed endotracheal
tube (Lo-Contour™ Magill, Mallinckrodt Medical, Ath-
lone, Ireland) the pigs were ventilated with pressure-
controlled ventilation modus (Galileo Gold, Hamilton
Medical, Rhaezuens, Switzerland). Arterial blood gas
analysis (ABL 625, Radiometer Copenhagen, Denmark)
including blood lactate measurement was performed
hourly and ventilation was adjusted accordingly. Contin-
uous infusion of ketamine (15 mg/kg/h), fentanyl (0.02
mg/kg/h) and midazolam (0.9 mg/kg/h) was adminis-
tered to maintain deep anesthesia throughout the
experiment. Character of respiration, heart rate, eye
movement and pain stimulus was used to confirm depth
of anesthesia; if any of these parameters indicated a les-
sening of anesthesia, infusion rates of anaesthetic agents
were increased.
Surgical procedure and randomization
Animals were kept under standard laboratory conditions
and fasted overnight before surgery. They received 2 g
ceftriaxon (Rocephin
® , Hoffmann-La Roche, Basel,
Switzerland) prior to surgery. The superior vena cava
through the jugular veins (Multi-Lumen Central Venous
Catheter, Arrow International, Reading, PA, USA) and
the internal carotid artery (Leadercath, Vygon, Écouen,
France) were instrumented to measure mean arterial
pressure (MAP) and central venous pressure. Following
frontoparietal cranial trepanation, a probe was inserted
in the frontal brain parenchyma to measure ICP
(Camino
® MPM-1 monitor, Integra Neurosciences,
Plainsboro, NJ, USA). The abdominal cavity was entered
through a midline incision and a urinary catheter (Gen-
tle-Flo™, Tyco Healthcare, Tullamore, Ireland) was
placed by cystostomy. Total hepatectomy was performed
according to a recently published technique [11] with a
Y-graft vascular prosthesis (Uni-Graft
® KD V ,I T V ,
Denkendorf, Germany) interposition. Intraoperative
blood loss was substituted with porcine erythrocyte and
fresh-frozen plasma units. After stabilisation of the
hemodynamic situation pigs were randomized in two
groups receiving standardized intensive care therapy
alone (n = 5) or additional periodic connection to the
extracorporeal dummy device system (n = 5).
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Cyclic connection of the pigs to the extracorporeal
dummy device system started approximately twelve hours
after hepatectomy for a time period of twelve hours. This
connection cycles were continued every twelve hours for
twelve hours. To simulate the experimental setting of an
artificial or bioartificial liver assist device, pigs underwent
plasma separation (TPE, Prismaflex, Gambro, Hechingen,
Germany) with a mean blood flow rate of 120 mL/min
and a plasma separation rate of 20 mL/min using a plasma
filter (TPE 2000, Gambro, Hechingen, Germany) with a
m a x i m a lp o r es i z eo f0 . 5μm. The total extracorporeal
volume of the device system was 125 mL ± 10%. The
device system including the plasma filter was washed and
primed according to the manufacturer’si n s t r u c t i o n .
Heparin (250 U/h) was administered as necessary to avoid
clotting in the extracorporeal circuit of the dummy device.
The separated plasma fraction was completely returned to
the animal via the implanted central vein catheter without
any further plasma filtration/detoxification or plasma
exchange/replacement.
Preparation of donor fresh-frozen plasma and erythrocyte
units
Blood was collected in blood bag systems (500 mL,
Compoflex
® Fresenius HemoCare, Bad Homburg, Ger-
many) and centrifuged at 2,500 g for 20 minutes (Her-
aeus Cryofuge 5500i, Thermo Electron Corporation,
Langenselbold, Germany). Plasma fraction was pressed
into separate bags and shock-frozen at minus -80°C.
Erythrocytes were conserved with 100 mL SAG-Manni-
tol and stored at 4°C.
Standardized intensive care therapy
Animals remained in general anesthesia receiving pres-
sure-controlled ventilation until conclusion of the study
protocol (15-30 breaths/minute, tidal volume 6-12 mL/
kg and oxygen concentration 0.3-1.0, depending on oxy-
genation). Monitoring throughout the experiment
included electrocardiogram, ICP, MAP, central venous
pressure, oxygen saturation and core body temperature.
Urinary output, haemoglobin, lactate, serum electrolytes,
acid-base balance, blood gase analysis and blood glucose
levels were monitored hourly and immediately corrected
as required. The selected laboratory parameters like pro-
thrombin time, albumin, plasma protein, creatinine,
bilirubin and ammonia were measured before, after and
every eight hours after hepatectomy until death. All
blood samples were obtained from the arterial carotid
catheter. Norepinephrine, in combination with fresh-fro-
zen plasma, hydroxyethylstarch 6% (Voluven
® HES 130/
0.4, Fresenius, Bad Homburg, Germany) and sodium
chloride solution 0.9% were used to ensure hemody-
namic stability. Algorithms of fluid management,
ventilation and intensive care medication have already
been reported in detail [18]. Blood glucose levels were
maintained > 100 mg/dL with glucose 20% solution.
Packed erythrocyte units were given if haemoglobin
levels trend to decline below 6 g/dL. To prevent sponta-
neous bleeding eight fresh-frozen plasma units were
g i v e nw i t h i n2 4h o u r s .P i g sr e c e i v e df u r o s e m i d e( m a x i -
mum 1,000 mg/d) to maintain diuresis as long as possi-
ble. Antibiotic prophylaxis with 2 g ceftriaxon was
continued daily. Death was defined as a decline of MAP
below 30 mmHg under maximal vasopressor support.
Laboratory analysis
All biochemical parameters as prothrombin time, creati-
nine, albumin, bilirubin, ammonia, total plasma protein
and blood count were measured by the certified labora-
tories of the University Hospital Tuebingen (Zentralla-
bor, Innere Medizin IV, University Hospital Tuebingen,
Germany). Sample analysis was conducted within 1 hour
of collection at each time point.
Endotoxin was measured by a Limulus-Amoebozyte-
Lysate assay (Charles River Endosafe, Charleston, SC,
USA) and performed according to the manufacturer’s
instruction. In brief, all endotoxin samples were
obtained from the arterial catheter and collected in ster-
ile pyrogen-free vacuum tubes (Endo Tube ET, Chromo-
genics AB, Moelndal, Sweden). Subsequently probes
were centrifuged at 3,000 g for 10 minutes. The super-
natant was immediately transferred into biopur-grade
reaction tubes (Eppendorf AG, Hamburg, Germany) and
stored at -80°C.
After thawing, samples were heat inactivated at 80°C
for 10 minutes. Samples underwent cooling for 1 minute
at 0°C and ultrasonic bathing for 3 minutes followed by
centrifugation at 10,000 g for 60 minutes at 4°C. Super-
natants were transferred in micro plates (Microtest 96,
Becton Dickinson, Franklin Lakes, NJ, USA) and mea-
sured kinetically with the (Endosafe
® Endochrome-K™,
Charles River Endosafe, Charleston, SC, USA). Spike
and recovery assays were performed.
Statistical Analysis
Mean values of the selected variables determined before,
during and after hepatectomy were compared by t-Test,
(JMP
® 4.0, SAS Institute, Cary, NC, USA). A p value <
0.05 was considered significant. Results are reported as
mean ± standard deviation (SD). Figures are given as
mean ± standard error of mean (SEM) of a minimum of
two animals per study group.
Results
Survival
Mean operation time (181 ± 24 minutes) and intrao-
perative blood loss caused by the blood volume
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not differ between both groups. Overall postoperative
survival of the pigs was 100% after 24 hours. All animals
(10/10) (100%) died due to multiple-organ failure and
cerebral edema within 63 ± 5 hours after hepatectomy.
Survival of the dummy device group (n = 5) was 74 ± 6
hours in contrast to 53 ± 5 hours survival of the control
group (n = 5), which was statistically significant (p <
0.05). Kaplan-Meier survival plot of both groups is
shown as Figure 1.
Clinical course of body temperature
After completing surgical procedures, body temperature
was as low as 35.8 ± 0.4°C (dummy device group) and
35.7 ± 0.3°C (control group). Pigs were slightly warmed
with warming blankets. The further course of body tem-
perature is demonstrated in Figure 2A. Temperature of
the control group pigs could be increased to values of
38.2 ± 0.7°C 24 hours after hepatectomy. Body tempera-
ture of the dummy device group which received the first
connection cycle twelve hours after hepatectomy could
not be raised to more than 36.5 ± 0.5°C 24 hours after
hepatectomy due to extracorporeal cooling, which was
statistically significant (p < 0.05). A cyclic decline in
body temperature could be observed in correlation to
the connection cycles but no further statistical signifi-
cance was noticed.
Cardiopulmonary parameters and ICP monitoring
Ventilation deteriorated progressively during anhepatic
coma until death. No significant differences concerning
oxygen concentration, maximal airway pressure, positive
end expiratory pressure and tidal volume could be
detected between both groups. No significant differences
were found in hemodynamic parameters between both
groups during surgical procedures and further anhepatic
coma. The amount of fluid administered and the central
venous pressure - positive end-expiratory pressure
which was targeted did not differ significantly either
between both groups [see additional file 1]. A trend to
more hemodynamic stability during anhepaty could be
demonstrated by the nearly identical clinical course of
MAP but a lower amount of vasopressor support in the
dummy device group (Figure 2B and 2C). ICP started at
the elevated level of 23 ± 5 mmHg (control group) and
20 ± 2 (dummy device group) caused by the unphysiolo-
gical supine position. During surgical procedures values
did not change. Subsequently values increased up to
levels of 45 ± 17 mmHg (control group) and 40 ± 8
(dummy device group) when death occurred, but no sta-
tistically significant differences could be observed in the
course of ICP (Figure 2D).
Laboratory analysis
Laboratory values of all pigs were found to start within
the normal range at the time of surgery (table 1). Post-
operatively, biochemical parameters as blood count, total
plasma protein, albumin, prothrombin time, creatinine,
ammonia and endotoxin did not differ significantly.
Approximately 6 hours after surgery blood lactate was
2.2 ± 0.3 mmol/L in both study groups representing
equal outcome after completing all surgical procedures.
The further clinical course of the selected parameters
creatinine, ammonia and lactate is shown in Figure 3A-C.
Significant (p < 0.05) lower laboratory values of the
dummy device group animals were detected starting
from 16 hours after hepatectomy for blood lactate (1.9 ±
0.2 vs. 2.5 ± 0.5 mM/L), from 40 hours for serum creati-
nine (1.5 ± 0.2 vs. 2.0 ± 0.3 mg/dL) and from 48 hours
for arterial ammonia (273 ± 122 vs. 1345 ± 700 μg/dL)
until death as shown in table 1. At time of death no sta-
tistically significance for creatinine, ammonia and lactate
values was noticed representing death due to ALF. Endo-
toxin measurements remained at baseline over the
observed survival time in all control animals, but 60% (3/
5) of the dummy device pigs showed a significant rise of
endotoxin levels (356 ± 373 vs. 9 ± 7 pg/mL, p < 0.05) at
time of death (Figure 3D).
Autopsy
At autopsy massive ascites (2,000 to 3,000 mL) was
found in all animals, no signs of intestinal congestion
were noticed and all vascular grafts were found to be
regularly patent without either signs of thrombosis or
evidence of bleeding from anastomosis side. Kidneys
were swollen and showed hemorrhagic infarctions; his-
tological examinations confirmed tubular necrosis.
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Figure 1 Kaplan-Meier survival plot for control and dummy
device group. The control group as demonstrated by the grey line
survived 53 ± 5 hours in contrast to the significant longer survival
(p < 0.05) of the dummy device group (74 ± 6 hours) as
demonstrated by the black line in relation to time after
hepatectomy (in hours).
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Figure 2 Profile of body temperature, MAP, norepinephrine concentration and ICP in control and dummy device group.C h a r tA
demonstrates the clinical course of body temperature (C°) of the control (grey line) and dummy device group (black line). A cyclic decline could
be observed in correlation to the connection cycles. Body temperature, 24 hours after hepatectomy, differ statistically significant (p < 0.05)
between the groups. Furthermore chart B and C demonstrate more hemodynamic stability of the dummy device (black line) versus the control
group (grey line) presented by the nearly identical course of MAP but the lower amount of vasopressor support. ICP values are presented in
chart D. Values did not differ statistically significant between the groups over the observed survival. All values are given as mean ± SEM in
relation to time after hepatectomy (in hours). Bold marks indicate connection cycles to the dummy device.
Table 1 Body temperature and laboratory values of selected biochemical parameters after hepatectomy.
post-surgery 24 h 48 h 72 h Exitus
Control
group
Dummy
device
Control
group
Dummy
device
Control
group
Dummy
device
Control
group
Dummy
device
Control
group
Dummy
device
Temperature (°C) 35.7 ± 0.3 35.8 ± 0.4 38.2 ± 0.7* 36.5 ± 0.5* 37.7 ± 1.3 37.1 ± 0.7 - 37.4 ± 0.4 38.1 ± 1.5 37.3 ± 2.0
Total protein (g/dL) 4.0 ± 0.9 3.9 ± 0.2 5.8 ± 1.0 4.9 ± 0.5 5.1 ± 0.3 5.5 ± 1.0 - 6.3 ± 0.2 4.4 ± 1.7 4.0 ± 1.1
Albumin (g/dL) 2.4 ± 0.6 2.4 ± 0.1 3.3 ± 0.5 2.8 ± 0.3 2.8 ± 0.2 3.1 ± 0.5 - 3.5 ± 0 2.4 ± 1.0 2.2 ± 0.6
PT (%) 83 ± 25 97 ± 18 60 ± 17 41 ± 5 50 ± 17 56 ± 14 - 52 ± 4 43 ± 24 34 ± 11
Creatinine (mg/dL) 1.3 ± 0.2 1.3 ± 0.2 1.6 ± 0.3 1.3 ± 0.1 2.6 ± 0.6* 1.4 ± 0.2* - 2.1 ± 0.8 2.9 ± 0.8 2.2 ± 0.7
Platelets (10
3/μL) 240 ± 112 331 ± 99 180 ± 59 215 ± 74 128 ± 79 137 ± 43 - 133 ± 63 90 ± 33 59 ± 29
Haemoglobin (g/dL) 9.5 ± 1.7 9.7 ± 1.7 8.8 ± 1.1 8.5 ± 0.7 6.7 ± 2.0 8.4 ± 1.1 - 8.8 ± 0.2 5.3 ± 1.5 6.5 ± 1.1
Ammonia (μg/dL) 310 ± 98 276 ± 93 411 ± 169 233 ± 65 1345 ± 700* 273 ± 122* - 307 ± 210 2473 ±
1808
977 ± 499
Bilirubin (mg/dL) 0.2 ± 0.1 0.3 ± 0.2 2.0 ± 0.7 1.6 ± 0.4 2.8 ± 1.8 3.1 ± 0.9 - 3.8 ± 0 2.3 ± 1.9 2.3 ± 0.8
Leukocytes (10
3/μL) 12 ± 5 17 ± 3 24 ± 15 35 ± 11 23 ± 14 30 ± 11 - 27 ± 14 14 ± 6 9 ± 9
Lactate (mM) 2.9 ± 1.7 2.9 ± 1.7 3.7 ± 1.1* 2.2 ± 0.4* 7.4 ± 3.1* 2.9 ± 0.9* 4.6 ± 3.3 10.0 ± 3.3 8.7 ± 2.0
The course of body temperature and values of selected laboratory parameters after surgery, 24 hours, 48 hours, 72 hours and at time of death. Bold values*
indicates a statistically significant difference (p < 0.05) between the control and dummy device group. Values are reported as mean ± SD.
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oedema.
Discussion
Based on preliminary pig studies with a model of total
hepatectomy [11] and standardized intensive care ther-
apy [18], we performed the presented study to evaluate
a dummy device effects on hemodynamics, body tem-
perature and survival.
Although the used dummy device system was not cre-
ated as a therapeutic approach, a significant survival bene-
fit of more than 20 hours was noticed. The courses and
values of the selected laboratory parameters ammonia, lac-
tate, creatinine or endotoxin which are appropriate to ver-
ify different aspects of detoxification were analysed before
and after connection to the dummy device. As it was
expected, no significant changes of these parameters were
observed during or after dummy device connections.
Therefore it was demonstrated that these parameters were
neither improved nor changed by cyclic application of the
dummy device. Our observations were confirmed by the
recently published animal study of Ho et al. [25] analysing
selective plasma filtration in a porcine model of ALF. A
nearly identical experimental device setting (plasma
separation with return of the undetoxified plasma) served
as a control group in which no detoxification aspect was
noticed and survival remained comparable to the sham
(diseased) control group.
Body temperature of all pigs was aimed to maintain
within a range of 38 ± 0.5°C by warming blankets, but
this parameter was significantly affected by the cyclic
connection to the extracorporeal device. Moderate
hypothermia has already been established as a method
for organ and brain protection by reducing oxygen
metabolism in severe neurosurgical traumas or systemic
disorders such as ALF [26]. Surprisingly the intracranial
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Figure 3 Profile of creatinine, ammonia, lactate and endotoxin in control and dummy device group. The chart demonstrates the course
of the selected laboratory values creatinine, A, ammonia, B, lactate, C and endotoxin, D of the control (grey line) and dummy device group
(black line) animals. A statistical significance (p < 0.05) could be detected for blood lactate starting from 16 hours, serum creatinine from 40
hours and arterial ammonia from 48 hours after hepatectomy. At time of death no differences were noticed for creatinine, ammonia and lactate,
but a statistically significant (p < 0.05) rise of endotoxin serum levels indicated severe sepsis in 60% of the animals surviving beyond 60 hours
from hepatectomy. Values are given as mean ± SEM in relation to time after hepatectomy (in hours). Bold marks indicate connection cycles to
the dummy device.
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Page 6 of 8pressure could not be decreased in our experimental
setting. This phenomenon might be associated to the
fact that the cyclic hypothermia of 1-1.5°C was not
effective for decreasing ICP.
The study might be criticized for the absence of an
additionally warmed dummy device group with body
temperatures corresponding to those of the presented
control group or an additionally cooled control group.
But the presented study was not designed to confirm the
already experimentally [27] and clinically [28] proven
merits of therapeutic hypothermia by cooling down the
animals to a predefined temperature. Our objective was
to analyse the clinical effects of a dummy device to verify
their potential impact on survival. Therefore we could
demonstrate that even slight episodes of hypothermia
which remained considerably above the required interval
for a therapeutical hypothermia do significantly enhance
hemodynamics and consecutively anhepatic survival.
Although antibiotic prophylaxis was administered
daily, a significant rise of endotoxin levels, paralleled by
a leukocyte drop (data not shown) occurred at time of
death in 60% of the dummy device group animals sur-
viving beyond 60 hours. This observation confirmed the
fact that relevant inflammation mediators were not
eliminated by binding to the plasma separation filter.
The onset of sepsis destabilized the only just compen-
sated circulation of the organism resulting in a sudden
uncontrollable circulation failure, contrary to the more
progressive course in multiple-organ failure. It therefore
marks definitively an endpoint of anhepatic survival
which can hardly be prolonged further. Theoretically
this phenomenon could also be associated with
hypothermia [29], but it is hardly conceivable that cyclic
hypothermia of 1-1.5°C causes a relevant destabilisation
of the immune system within this experimental setting.
Standardized intensive care management prolonged
anhepatic survival. In combination with slight hypother-
mia it could be extended up to 88 hours. Therefore the
anhepatic porcine model provides a valuable tool for
screening functionality and safety of liver support tech-
nologies but the efficacy of liver assist device should not
be assessed by an anhepatic survival benefit. It should
be mentioned that as much as you prolong anhepatic
survival the more side-effects like potential transient
hypothermia or septical complications will disturb the
reproducibility of the model. Significant elimination of
hepatotoxic substances or relevant detoxification result-
ing in increased hemodynamic stability could be better
surrogate parameters to verify the effectiveness of any
therapeutical approach.
Conclusions
Episodes of slight hypothermia induced by cyclic con-
nection to the extracorporeal dummy device produced a
significant survival benefit of more than 20 hours
through organ protection and hemodynamic stabilisa-
t i o n .S e p s i sa sas e v e r ec o m p l i c a t i o no fA L Fw a so n l y
noticed in the dummy device group animals surviving
beyond 60 hours which definitively marks the endpoint
of survival in the anhepatic porcine model. Animal stu-
dies evaluating a liver assist device efforts should espe-
cially address the aspect of even slight transient
hypothermia induced by the extracorporeal cooling in
their experimental setting.
Additional material
Additional file 1: Fluid management and central venous pressure -
positive end-expiratory pressure (PEEP) of the control and dummy
device group. Total amount of fluid administered to the animals
subdivided in porcine fresh-frozen plasma (300 mL/unit), porcine
erythrocyte (300 mL/unit) and colloidal/crystalloid (500 mL/unit) units, of
the control and dummy device group after hepatectomy. All values are
given as mean ± SD subsumed in 12 hour time periods in relation to
time after hepatectomy. Central venous pressure - positive end-expiratory
pressure (PEEP) as a parameter of preload is given to demonstrate
adequate preload without dilution effects.
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